Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 04, 2025 07:00 ET | Source: MapLight Therapeutics, Inc.

MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress

Topline results from Phase 2 ZEPHYR trial of ML-007C-MA for schizophrenia expected in the second half of 2026Topline results from Phase 2 VISTA trial of ML-007C-MA for Alzheimer’s disease psychosis...
April 29, 2021 12:54 ET | Source: Acumen Research and Consulting

Muscarinic Acetylcholine Receptor Market In Asia Pacific Is Expected To Witness Faster Growth During Forecast Period 2021-2030: Acumen Research And Consulting

Acumen Research and Consulting, a global provider of market research studies, recently added a forthcoming report titled “Muscarinic Acetylcholine Receptor Market – Global Industry Analysis, Market...